Lyell Immunopharma
Price & Volume
Stats
See moreOpen | $8.45 |
Previous Close | $8.27 |
Day Range | $7.72-$8.45 |
52W Range | $8.21-$45 |
Market Cap | $213.4M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $27,000 |
Revenue Growth (YoY) | -50% |
Gross Profit (12 Mos) | $27,000 |
Diluted EPS | -$12.86 |
News
See moreYahoo Finance • 2 months ago
Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls
Yahoo Finance • 4 months ago
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
Yahoo Finance • 10 months ago
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Yahoo Finance • 10 months ago
Lyell's Ronde-cel Shows Durable Complete Responses With Manageable Safety In High-Risk LBCL
About
CEO | Dr. Lynn Seely M.D., Ph.D. |
CFO | Ms. Smital Shah M.B.A. |
Address | 201 Haskins Way, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |